Evidence map›Paper›PMID 26313004›Full record

ArticlePLoS genetics2015

APLP2 Regulates Refractive Error and Myopia Development in Mice and Humans.

Andrei V Tkatchenko, Tatiana V Tkatchenko, Jeremy A Guggenheim, Virginie J M Verhoeven, Pirro G Hysi, Robert Wojciechowski, Pawan Kumar Singh, Ashok Kumar, Gopal Thinakaran, Consortium for Refractive Error and Myopia (CREAM) and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 4 pooled it
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 4 syntheses or guidelines pooled it, 101 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Insights into Myopia from Mouse Models.Annual review of vision science · 2024
    Review
  16. Review
  17. Article
  18. The Role of Retinal Dysfunction in Myopia Development.Cellular and molecular neurobiology · 2023
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 3 countries.

Andrei V TkatchenkoDepartment of Ophthalmology, Columbia University, New York, New York, United States of America; Department of Pathology and Cell Biology, Columbia University, New York, New York, United States of America.
Tatiana V TkatchenkoDepartment of Ophthalmology, Columbia University, New York, New York, United States of America.
Jeremy A GuggenheimSchool of Optometry & Vision Sciences, Cardiff University, Cardiff, United Kingdom.
Virginie J M VerhoevenDepartment of Ophthalmology, Erasmus Medical Center, Rotterdam, Netherlands; Department of Epidemiology, Erasmus Medical Center, Rotterdam, Netherlands.
Pirro G HysiDepartment of Twin Research and Genetic Epidemiology, King's College London School of Medicine, London, United Kingdom.
Robert WojciechowskiDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America; Statistical Genetics Section, Inherited Disease Research Branch, National Human Genome Research Institute (NIH), Baltimore, Maryland, United States of America.
Pawan Kumar SinghDepartment of Ophthalmology, Wayne State University, Detroit, Michigan, United States of America.
Ashok KumarDepartment of Ophthalmology, Wayne State University, Detroit, Michigan, United States of America; Department of Anatomy and Cell Biology, Wayne State University, Detroit, Michigan, United States of America.
Gopal ThinakaranDepartments of Neurobiology, Neurology, and Pathology, University of Chicago, Chicago, Illinois, United States of America.
Consortium for Refractive Error and Myopia (CREAM)
Cathy WilliamsSchool of Social and Community Medicine, University of Bristol, Bristol, United Kingdom.
Columbia University · USMichigan United · USCardiff University · GBErasmus MC · NLKing's College London · GBNational Human Genome Research Institute · USUniversity of Bristol · GBUniversity of Chicago · US

Funding

Instrumentation, Fabrication, and Design CoreP30EY019007 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Xin Zhang · 2010 to 2026
$12.9M
Genetic Epidemiology of Complex TraitsZIAHG200327 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI BAILEY-WILSON, JOAN ELLEN · 2009 to 2022
$10.5M
STRUCTURAL AND FUNCTIONAL ANALYSIS OF PRESENILINSR01AG019070 · NIA · UNIVERSITY OF CHICAGO · PI THINAKARAN, GOPAL · 2001 to 2015
$4.9M
Genetics of refractive error development in the mouse modelR01EY023839 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI TKATCHENKO, ANDREI V. · 2014 to 2017
$1.6M
Toll-like receptors and bacterial endophthalmitisR01EY019888 · NEI · WAYNE STATE UNIVERSITY · PI KUMAR, ASHOK · 2010 to 2014
$1.6M
Gene-environment-wide interaction studies of ocular refractionK08EY022943 · NEI · JOHNS HOPKINS UNIVERSITY · PI WOJCIECHOWSKI, ROBERT J. · 2013 to 2017
$776k
Feasibility of a mouse model of myopiaR21EY018902 · NEI · WAYNE STATE UNIVERSITY · PI TKATCHENKO, ANDREI V. · 2009 to 2010
$405k
Department of Health CDF-2009-02-35Medical Research Council MC_PC_15018NEI NIH HHS K08 EY022943NEI NIH HHS K08EY022943NEI NIH HHS P30 EY019007NEI NIH HHS R01 EY019888NEI NIH HHS R01EY019888NEI NIH HHS R01 EY023839NEI NIH HHS R01EY023839NEI NIH HHS R21 EY018902NEI NIH HHS R21EY018902NIA NIH HHS R01 AG019070NIA NIH HHS R01AG019070Wellcome Trust 102215
6 · The paper itself

Abstract

Myopia is the most common vision disorder and the leading cause of visual impairment worldwide. However, gene variants identified to date explain less than 10% of the variance in refractive error, leaving the majority of heritability unexplained ("missing heritability"). Previously, we reported that expression of APLP2 was strongly associated with myopia in a primate model. Here, we found that low-frequency variants near the 5'-end of APLP2 were associated with refractive error in a prospective UK birth cohort (n = 3,819 children; top SNP rs188663068, p = 5.0 × 10-4) and a CREAM consortium panel (n = 45,756 adults; top SNP rs7127037, p = 6.6 × 10-3). These variants showed evidence of differential effect on childhood longitudinal refractive error trajectories depending on time spent reading (gene x time spent reading x age interaction, p = 4.0 × 10-3). Furthermore, Aplp2 knockout mice developed high degrees of hyperopia (+11.5 ± 2.2 D, p < 1.0 × 10-4) compared to both heterozygous (-0.8 ± 2.0 D, p < 1.0 × 10-4) and wild-type (+0.3 ± 2.2 D, p < 1.0 × 10-4) littermates and exhibited a dose-dependent reduction in susceptibility to environmentally induced myopia (F(2, 33) = 191.0, p < 1.0 × 10-4). This phenotype was associated with reduced contrast sensitivity (F(12, 120) = 3.6, p = 1.5 × 10-4) and changes in the electrophysiological properties of retinal amacrine cells, which expressed Aplp2. This work identifies APLP2 as one of the "missing" myopia genes, demonstrating the importance of a low-frequency gene variant in the development of human myopia. It also demonstrates an important role for APLP2 in refractive development in mice and humans, suggesting a high level of evolutionary conservation of the signaling pathways underlying refractive eye development.

Indexed as

AdolescentAmyloid beta-Protein PrecursorAnimalsChildChlorocebus aethiopsGene-Environment InteractionGenetic Predisposition to DiseaseGenetic VariationHumansHyperopiaMiceMice, Inbred C57BLMice, KnockoutMonkey DiseasesMyopiaNerve Tissue ProteinsAmyloid beta-Protein PrecursorAPLP2 protein, humanAplp2 protein, mouseNerve Tissue Proteins

Identifiers

PMID26313004
PMCPMC4551475
OpenAlexW1772688606

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.